Shareholders Can Be Confident That LifeVantage's (NASDAQ:LFVN) Earnings Are High Quality

When companies post strong earnings, the stock generally performs well, just like LifeVantage Corporation's (NASDAQ:LFVN) stock has recently. Our analysis found some more factors that we think are good for shareholders.

Our free stock report includes 1 warning sign investors should be aware of before investing in LifeVantage. Read for free now.
earnings-and-revenue-history
NasdaqCM:LFVN Earnings and Revenue History May 13th 2025
Advertisement

A Closer Look At LifeVantage's Earnings

Many investors haven't heard of the accrual ratio from cashflow, but it is actually a useful measure of how well a company's profit is backed up by free cash flow (FCF) during a given period. In plain english, this ratio subtracts FCF from net profit, and divides that number by the company's average operating assets over that period. You could think of the accrual ratio from cashflow as the 'non-FCF profit ratio'.

As a result, a negative accrual ratio is a positive for the company, and a positive accrual ratio is a negative. That is not intended to imply we should worry about a positive accrual ratio, but it's worth noting where the accrual ratio is rather high. To quote a 2014 paper by Lewellen and Resutek, "firms with higher accruals tend to be less profitable in the future".

LifeVantage has an accrual ratio of -0.27 for the year to March 2025. That indicates that its free cash flow quite significantly exceeded its statutory profit. In fact, it had free cash flow of US$12m in the last year, which was a lot more than its statutory profit of US$9.15m. LifeVantage's free cash flow improved over the last year, which is generally good to see.

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

Our Take On LifeVantage's Profit Performance

As we discussed above, LifeVantage's accrual ratio indicates strong conversion of profit to free cash flow, which is a positive for the company. Because of this, we think LifeVantage's underlying earnings potential is as good as, or possibly even better, than the statutory profit makes it seem! And on top of that, its earnings per share have grown at an extremely impressive rate over the last year. At the end of the day, it's essential to consider more than just the factors above, if you want to understand the company properly. So if you'd like to dive deeper into this stock, it's crucial to consider any risks it's facing. Case in point: We've spotted 1 warning sign for LifeVantage you should be aware of.

This note has only looked at a single factor that sheds light on the nature of LifeVantage's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. Some people consider a high return on equity to be a good sign of a quality business. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks with significant insider holdings to be useful.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About NasdaqCM:LFVN

LifeVantage

Engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, pre and pro-biotics and skin and hair care products.

Flawless balance sheet and undervalued.

Advertisement

Weekly Picks

VA
valuebull
GOAI logo
valuebull on Eva Live ·

Is this the AI replacing marketing professionals?

Fair Value:US$7.4350.9% undervalued
15 users have followed this narrative
0 users have commented on this narrative
3 users have liked this narrative
ZA
PME logo
ZayaanS on Pro Medicus ·

Pro Medicus: The Market Is Confusing a Lumpy Quarter With a Broken Business

Fair Value:AU$196.7838.3% undervalued
26 users have followed this narrative
4 users have commented on this narrative
18 users have liked this narrative
ST
WBD logo
SteveGruber on Warner Bros. Discovery ·

The Rising Deal Risk That Helped Sink Netflix’s $72 Billion Bid for Warner Bros. Discovery  

Fair Value:US$18.1754.1% overvalued
5 users have followed this narrative
1 users have commented on this narrative
3 users have liked this narrative
PD
VRT logo
pdixit1 on Vertiv Holdings Co ·

The Infrastructure AI Cannot Be Built Without

Fair Value:US$408.6438.9% undervalued
32 users have followed this narrative
3 users have commented on this narrative
13 users have liked this narrative

Updated Narratives

AS
STO logo
astratov on Santos ·

Santos: Undervalued After Takeover Fallout

Fair Value:AU$8.8917.7% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AN
andre_santos
O logo
andre_santos on Realty Income ·

Realty Income - A Fundamental and Historical Valuation

Fair Value:US$73.4611.8% undervalued
29 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
HP
MSFT logo
HpN on Microsoft ·

A Structured Counter‑Analysis of "The Leaking Dreadnought"

Fair Value:US$509.8219.4% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

DA
davidlsander
UBI logo
davidlsander on Ubisoft Entertainment ·

Is Ubisoft the Market’s Biggest Pricing Error? Why Forensic Value Points to €33 Per Share

Fair Value:€33.888.2% undervalued
65 users have followed this narrative
5 users have commented on this narrative
28 users have liked this narrative
KA
NU logo
kabz2342 on Nu Holdings ·

Nu holdings will continue to disrupt the South American banking market

Fair Value:US$64.377.0% undervalued
48 users have followed this narrative
3 users have commented on this narrative
27 users have liked this narrative
AN
AnalystConsensusTarget
MSFT logo
AnalystConsensusTarget on Microsoft ·

Analyst Commentary Highlights Microsoft AI Momentum and Upward Valuation Amid Growth and Competitive Risks

Fair Value:US$59631.1% undervalued
1298 users have followed this narrative
2 users have commented on this narrative
10 users have liked this narrative